SCHEMBL25832189

SCHEMBL25832189

Cc1ccc2c(c1)C(=NCc1ccccc1)CC1(CCCCC1)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACAT2 Q9BWD1 1/20 0.39
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
C3AR1 Q16581 1/20 0.36
SIGMAR1 Q99720 2/20 0.35
NPSR1 Q6W5P4 1/20 0.33
NPC1 O15118 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP46A1 Q9Y6A2 1/20 0.32
KDM4E B2RXH2 2/20 0.32
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
BACE1 P56817 1/20 0.31
HTR1A P08908 4/20 0.31
ADRA1B P35368 3/20 0.31
ADRA1A P35348 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25832056 0.78 ALDH1A1 (0.38) ACAT2ALDH1A1MAPTC3AR1SIGMAR1
SCHEMBL25832502 0.77 THRB (0.34) MAPTNPSR1
SCHEMBL25832069 0.72 MAPT (0.40) ALDH1A1MAPTC3AR1NPC1NFKB1
SCHEMBL25832175 0.70 KDM4E (0.52) ALDH1A1NPSR1SMN1; SMN2KDM4EHTT
SCHEMBL25832159 0.63 CYP19A1 (0.44) ALDH1A1MAPTC3AR1MEN1KMT2A
SCHEMBL30529399 0.61 ALDH1A1 (0.41) ALDH1A1SIGMAR1SMN1; SMN2
SCHEMBL11706445 0.61 ALDH1A1 (0.41) ALDH1A1SIGMAR1SMN1; SMN2
SCHEMBL17041223 0.60 NPC1 (0.40) ALDH1A1MAPTSIGMAR1NPC1RAB9A
SCHEMBL16705970 0.60 P2RX7 (0.37) ALDH1A1MAPTSIGMAR1NPSR1KMT2A
SCHEMBL2704410 0.58 G6PC1 (0.60) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702427-B2 Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702427-B2 Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same HAVCR2, HPD, CYP24A1 ACAT2 4354/4885ALDH1A1 2445/4885MAPT 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.